APA引文

Uysal-Onganer, P., D’Alessio, S., Mortoglou, M., Kraev, I., & Lange, S. (2021). Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. Int J Mol Sci.

Citação norma Chicago

Uysal-Onganer, Pinar, Stefania D’Alessio, Maria Mortoglou, Igor Kraev, and Sigrun Lange. "Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures." Int J Mol Sci 2021.

MLA引文

Uysal-Onganer, Pinar, et al. "Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures." Int J Mol Sci 2021.